Acyl coenzyme A: Cholesterol acyltransferase inhibition and hepatic apolipoprotein B secretion

Clinica Chimica Acta

Volumn 286, Issue 1-2, 1999, Pages 231-242

  Burnett, John R ^a   Wilcox, Lisa J ^a   Huff, Murray W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

ACAT inhibitor; ACAT1; ACAT2; Apolipoprotein B metabolism; Kinetics

Indexed keywords

1 (2 BROMOETHYLAMINO) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; LECIMIBIDE; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; ENZYME SPECIFICITY; HUMAN; KINETICS; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEINS B; CHOLESTEROL ESTERS; ENZYME INHIBITORS; LIVER; STEROL O-ACYLTRANSFERASE;

EID: 0032866660     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(99)00104-7     Document Type: Conference Paper

References (51)

1. Suckling K.E., Strange E.F. Role of acyl-CoA:cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res. 26:1985;647-671.
2. Chang T.Y., Chang C.C.Y., Cheng D. Acyl-coenzyme A:cholesterol acyltransferase. Annu Rev Biochem. 66:1997;613-638.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
4. Meiner V.L., Cases S., Myers H.M., et al. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci USA. 93:1996;14041-14046.
5. Chang C.C.Y., Huh H.Y., Cadigan K.M., Chang T.Y. Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. J Biol Chem. 268:1993;20747-20755.
6. Meiner V., Tam C., Gunn M.D., et al. Tissue expression studies on the mouse acyl-CoA: cholesterol acyltransferase gene (Acact): findings supporting the existence of multiple cholesterol esterification enzymes in mice. J Lipid Res. 38:1997;1928-1933.
7. Yang H., Bruner D.A., Gleeson A., et al. Sterol esterification in yeast: a two-gene process. Science. 272:1996;1353-1356.
8. Oelkers P., Behari A., Cromley D., Billheimer J.T., Sturley S.L. Characterization of two human genes encoding acyl coenzyme A-cholesterol acyltransferase related enzymes. J Biol Chem. 273:1998;26765-26778.
9. Largis E.E., Wang C.H., DeVries V.G., Schaffer S.A. CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption. J Lipid Res. 30:1989;681-690.
10. Maduskuie T.P. Jr, Wilde R.G., Billheimer J.T., et al. Design, synthesis, and structure-activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors. J Med Chem. 38:1995;1067-1083.
11. Kawasaki T., Miyazaki A., Hakamata H., Matsuda H., Horiuchi S. Biochemical evidence for oligomerization of rat adrenal acyl-coenzyme A: cholesterol acyltransferase. Biochem Biophys Res Commun. 244:1998;347-352.
12. Cases S., Novak S., Zheng Y.W., et al. ACAT-2, a second mammalian acyl coA: cholesterol acyltransferase: its cloning, expression, and characterization. J Biol Chem. 273:1998;26755-26771.
13. Anderson R.A., Joyce C., Davis M., et al. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem. 273:1998;26747-26754.
14. Lee O., Chang C.C.Y., Lee W., Chang T.Y. Immunodepletion experiments suggest that acyl-coenzyme A:cholesterol acyltransferase-1 (ACAT-1) protein plays a major catalytic role in adult human liver, adrenal gland, macrophages, and kidney, but not in intestines. J Lipid Res. 39:1998;1722-1727.
15. Dixon J.L., Ginsberg H.N. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J Lipid Res. 34:1993;167-179.
16. Yao Z., McLeod R.S. Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins. Biochim Biophys Acta. 1212:1994;152-166.
17. Sniderman A.D., Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb. 13:1993;629-636.
18. Thompson G.R., Naoumova R.P., Watts G.F. Role of cholesterol in regulating apolipoprotein B secretion by the liver. J Lipid Res. 37:1996;439-447.
19. Huff M.W., Burnett J.R. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion. Curr Opin Lipidol. 8:1997;138-145.
20. Brown M.S., Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science. 232:1986;34-47.
21. Dashti N. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells. J Biol Chem. 267:1992;7160-7169.
22. Qin W., Infante J., Wang S., Infante R. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes. Biochim Biophys Acta. 1127:1992;57-66.
23. Cianflone K.M., Yasruel Z., Rodriguez M.A., Vas D., Sniderman A.D. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesterol ester synthesis in the response to a fatty acid challenge. J Lipid Res. 31:1990;2045-2055.
24. Musanti R., Giorgini L., Lovisolo P., Pirillo A., Chiari A., Ghiselli G. Inhibition of acyl-CoA:cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells. J Lipid Res. 37:1996;1-14.
25. Avramoglu R.K., Cianflone K., Sniderman A.D. Role of the neutral lipid accessible pool in the regulation of secretion of apoB-100 lipoprotein particles by HepG2 cells. J Lipid Res. 36:1995;2513-2528.
26. Wilcox L.J., Barrett P.H.R., Newton R.S., Huff M.W. ApoB 100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011; an effect associated with enhanced intracellular degradation of apoB. Arterioscler Thromb Vasc Biol. 19:1999;939-949.
27. Kulinski A., Dulay D., Macri J., Newton R., Krause B., Adeli K. Effects of CI-1011 on the assembly and secretion of apolipoprotein B-containing lipoproteins in HepG2 cells [abstract]. XIII Int Symp Drugs Affect Lipid Metab. XIII:1998;76.
28. Kosykh V.A., Preobrazhensky S.N., Fuki I.V., et al. Cholesterol can stimulate secretion of apolipoprotein B in cultured human hepatocytes. Biochim Biophys Acta. 836:1985;385-389.
29. Tanaka M., Jingami H., Otani H., et al. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes. J Biol Chem. 268:1993;12713-12718.
30. Carr T.P., Hamilton R.L. Jr, Rudel L.L. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys. J Lipid Res. 36:1995;25-36.
31. Krause B.R., Anderson M., Bisgaier C.L., et al. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT. J Lipid Res. 34:1993;279-294.
32. Fukushima H., Anono S., Nakamura Y., Endo M., Imai T. The effect of N-(alpha-methylbenzyl)linoleamide on cholesterol metabolism in rats. J Atheroscler Res. 10:1969;403-414.
33. Heider J.G., Pickens C.E., Kelly L.A. Role of acyl-CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J Lipid Res. 24:1983;1127-1134.
34. Krause B.R., Pape M.E., Kieft K., et al. ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance. Arterioscler Thromb. 14:1994;598-604.
35. Liscum L., Underwood K.W. Intracellular cholesterol transport and compartmentation. J Biol Chem. 270:1995;15443-15446.
36. Synouri-Vrettakou S., Mitropoulos K.A. Acyl-coenzyme A: cholesterol acyltransferase. Transfer of cholesterol to its substrate pool and modulation of activity. Eur J Biochem. 133:1983;299-307.
37. Huff M.W., Telford D.E., Barrett P.H.R., Billheimer J.T., Gillies P.J. Inhibition of hepatic ACAT decreases apoB secretion in miniature pigs fed a cholesterol-free diet. Arterioscler Thromb. 14:1994;1498-1508.
38. Burnett J.R., Wilcox L.J., Telford D.E., Kleinstiver S.J., Barrett P.H.R., Huff M.W. Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol. Biochim Biophys Acta. 1393:1998;63-79.
39. Lee H.T., Sliskovic D.R., Picard J.A., et al. Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering in animals fed noncholesterol-supplemented diets. J Med Chem. 39:1996;5031-5034.
40. Ramharack R., Spahr M.A., Sekerke C.S., et al. CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys. Atherosclerosis. 136:1998;79-87.
41. Krause B.R., Auerbach B.J. ACAT inhibition by CI-1011 lowers plasma triglycerides in rats by enhancing the clearance of VLDL [abstract]. Atherosclerosis. 134:1997;128.
42. Nicolosi R.J., Wilson T.A., Krause B.R. The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters. Atherosclerosis. 137:1998;77-85.
43. Burnett J.R., Wilcox L.J., Telford D.E., et al. Inhibition of ACAT by avasimibe decreases both ULDL and LDC apolipoprotein B production in the miniature pig. J Lipid Res. 40:1999;1317-1327.
44. Pullinger C.R., North J.D., Teng B.B., Rafici V.A., RonhilddeBrito A.E., Scott J. The apo B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 30:1989;1065-1077.
45. Wu X., Sakata N., Lui E., Ginsberg H.N. Evidence for a lack of regulation of the assembly and secretion of apoliprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J Biol Chem. 269:1994;12375-12382.
46. Graham A., Wood J.L., Russell L.J. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells. Biochim Biophys Acta. 1302:1996;46-54.
47. Benoist F., Grand-Perret T. ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools. Arterioscler Thromb Vasc Biol. 16:1996;1229-1235.
48. Ooyen C., Zecca A., Zanelli T., Catapano A.L. Decreased intracellular degradation and increased secretion of apoB-100 in Hep G2 cells after inhibition of cholesteryl ester synthesis. Atherosclerosis. 130:1997;143-152.
49. Dixon J.L., Furukawa S., Ginsberg H.N. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem. 266:1991;5080-5086.
50. Adeli K. Regulated intracellular degradation of apolipoprotein B in semipermeable HepG2 cells. J Biol Chem. 269:1994;9166-9175.
51. Bonnardel J.A., Davis R.A. In HepG2 cells, translocation, not degradation, determines the fate of the de novo synthesized apolipoprotein B. J Biol Chem. 270:1995;28892-28896.